|
|
|
Volumn 26, Issue 3 SUPPL. 10, 1999, Pages 8-11
|
|
Docetaxel (Taxotere) and gemcitabine phase I and early phase II studies: Results to date and an overview of ongoing studies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOCETAXEL;
GEMCITABINE;
ADULT;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG TOLERABILITY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
DEOXYCYTIDINE;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0032787765
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (20)
|
